Alosetron for irritable bowel syndrome. Senior vice president of GlaxoSmithKline responds.
Palmer
James B D
JB
D002243:Carbolines / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D004345:Drug Industry; D004335:Drug and Narcotic Control; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans
D002243:Carbolines; D005765:Gastrointestinal Agents; C090840:alosetron